NRSA Training Core
NRSA 培训核心
基本信息
- 批准号:9976619
- 负责人:
- 金额:$ 88.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-21 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AppointmentAwardBiomedical ResearchBiometryCareer ChoiceCategoriesCertificationClinical ResearchClinical SciencesConduct Clinical TrialsDevelopmentDevelopment PlansDisciplineDiscipline of NursingDoctor of PharmacyDoctor of PhilosophyEducational CurriculumEducational workshopElementsEnrollmentEnsureEntrepreneurshipEpidemiologyEthicsEvaluationFosteringFoundationsFutureGrantHealth Insurance Portability and Accountability ActIndividualInstitutesLeadershipManuscriptsMentorsMethodologyNational Research Service AwardsOutcomePathway interactionsPublicationsRecordsResearchResearch DesignResearch PersonnelScienceSolidStudentsTNFSF15 geneTrainingTraining ProgramsTraining and EducationTraining and InfrastructureTranslational ResearchUniversitiesWisconsinWorkforce DevelopmentWritingbasecareercareer developmentclinical investigationexperienceinnovationmembernovelpost-doctoral trainingpre-doctoralprogramsrecruitresponsible research conductskillssuccesstool
项目摘要
Project Summary: The University of Wisconsin (UW) Graduate Program in Clinical Investigation (GPCI) was
developed by the UW Institute for Clinical and Translational Research (ICTR) and continues to be administered
by the ICTR Workforce Development group. GPCI houses multiple educational options for trainees in the
translational research continuum, but all are based on a common didactic foundation encompassing
biostatistics, epidemiology, clinical study design, clinical trials conduct, and the ethical and responsible conduct
of research. These essential curriculum elements are shared by the Certificate in the Fundamentals of Clinical
Research, the MS in Clinical Investigation, and two PhD programs. The PhD in Clinical Investigation is an
applied degree in which trainees focus on the creation of novel methodologies and tools for translational
science within the context of a specific biomedical discipline. The PhD in Clinical and Translational Science
leverages the core curriculum to give trainees the skills and tools necessary to move their biomedical research
along the translational pathway. Since its inception in 2008, GPCI has created a robust infrastructure for
training future members of the translational workforce that has allowed students in the program to accumulate
an impressive record of publications and research awards. For this NRSA application, new leadership has
been appointed distinct from the parental UL1. David DeMets, PhD, and Elizabeth Meyerand, PhD, both have
outstanding training records with mentees at all levels and are exemplary investigators in translational
sciences. Specific aims include maintaining both existing, high-performing PhD programs; applying an
integrated evaluation approach for continuous program improvement and longitudinal outcomes tracking; and
developing recruitment strategies to foster trainee diversity and success. In addition, a new postdoctoral
training program will be created for individuals with professional degrees (MD, DVM, PharmD, Nursing) to
enhance the translational potential of their prior research and provide a bridge to future independent careers in
translational sciences. All trainees will benefit from the existing comprehensive mentoring approach,
development of individualized career development plans (ICDP), and integrated program activities including
federally-mandated training (HIPAA, CITI, GCP, RCR, etc.) and additional training in team science, scientific
leadership, mentor-mentee relationships, and writing manuscripts and grants. GPCI also provides career
development seminars and workshops in innovation and entrepreneurship. The expanded program will support
15 two-year appointments combined in all pre and postdoctoral categories.
项目摘要:威斯康星大学(UW)临床研究研究生课程(GPCI)是
大学临床和翻译研究所(ICTR)开发,并继续管理
由ICTR劳动力发展小组。 GPCI为受训者提供多种教育选择
翻译研究连续性,但所有这些都是基于共同的教学基础
生物统计学,流行病学,临床研究设计,临床试验行为以及伦理和负责任的行为
研究。这些基本课程元素在临床基本面中由证书共享
研究,临床研究的MS和两个博士学位课程。临床研究的博士学位是
应用学位,学员专注于创建新颖的方法和翻译工具
在特定的生物医学学科的背景下进行科学。临床和转化科学博士学位
利用核心课程为学员提供移动其生物医学研究所需的技能和工具
沿着翻译路径。自2008年成立以来,GPCI为
培训转化劳动力的未来成员,使该计划的学生能够积累
出版物和研究奖的令人印象深刻的记录。对于此NRSA应用,新的领导
被任命为与父母UL1不同的任命。 David Demets博士和Elizabeth Meyerand博士都有
与各级受训者的出色培训记录,是翻译的模范研究者
科学。具体目的包括维护现有的高性能博士学位计划;应用一个
连续计划改进和纵向结果跟踪的综合评估方法;和
制定招聘策略以促进培训生的多样性和成功。此外,新的博士后
将为拥有专业学位(MD,DVM,PharmD,护理)的个人创建培训计划
增强其先前研究的翻译潜力,并为未来的独立职业提供桥梁
翻译科学。所有学员将从现有的全面指导方法中受益,
制定个性化的职业发展计划(ICDP),以及综合计划活动,包括
联邦化培训(HIPAA,花旗,GCP,RCR等)以及团队科学的其他培训,科学
领导力,导师的关系以及写作手稿和赠款。 GPCI还提供职业
创新和企业家精神的发展研讨会和讲习班。扩展的程序将支持
15个两年的任命合并为所有前和博士后类别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark E Burkard其他文献
Mark E Burkard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark E Burkard', 18)}}的其他基金
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10179607 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10381722 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Mechanisms of Plk1 at the mitotic centromere
有丝分裂着丝粒 Plk1 的机制
- 批准号:
10598560 - 财政年份:2021
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10305657 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10527350 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
染色体不稳定性对乳腺癌微管靶向药物敏感性的影响
- 批准号:
10062906 - 财政年份:2018
- 资助金额:
$ 88.61万 - 项目类别:
相似国自然基金
生态补奖背景下草原牧户实现自主性减畜的机制、路径和政策研究
- 批准号:72374130
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
草原生态补奖政策对牧户兼业行为的影响机理研究——以内蒙古为例
- 批准号:72363025
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:72104063
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
草原生态补奖政策激励-约束下牧民生产行为决策机制及生态效应
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:
相似海外基金
Mentoring of Early Career Researchers from Diverse Backgrounds
指导来自不同背景的早期职业研究人员
- 批准号:
10797793 - 财政年份:2023
- 资助金额:
$ 88.61万 - 项目类别:
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator
马里兰大学巴尔的摩生命科学发现 (UM-BILD) 加速器
- 批准号:
10783358 - 财政年份:2023
- 资助金额:
$ 88.61万 - 项目类别:
A novel framework for estimating personalized genomic variants of hypertension for precision medicine
用于估计高血压个性化基因组变异以实现精准医疗的新框架
- 批准号:
10685475 - 财政年份:2022
- 资助金额:
$ 88.61万 - 项目类别:
DataWiz-IN scholars program for Biomedical Informatics workforce in Indiana
DataWiz-IN 印第安纳州生物医学信息学劳动力学者计划
- 批准号:
10631297 - 财政年份:2022
- 资助金额:
$ 88.61万 - 项目类别:
Impaired Lipophagy and Lipid Droplet Accumulation in Osteoblasts
成骨细胞中的脂质自噬和脂滴积聚受损
- 批准号:
10619139 - 财政年份:2022
- 资助金额:
$ 88.61万 - 项目类别: